• Profile
Close

Genetic factors associated with pain severity, daily opioid dose requirement, and pain response among advanced cancer patients receiving supportive care

Journal of Pain and Symptom Management Apr 14, 2021

Yennurajalingam S, Astolfi A, Indio V, et al. - This study was attempted to ascertain the genetic factors associated with pain severity, daily opioid dose, and pain response in advanced cancer (AC) patients receiving supportive care. Logistic regression models and SKATO (Gene-block) analysis were used to evaluate pain phenotype. Researchers examined 174/178 (98%) patient samples. The result distinguished that SNPs of OPRM1, COMT, NFKBIA, CXCL8, IL-6, STAT6, and ARRB2 genes were correlated with pain severity, opioid daily dose, and pain response in AC receiving supportive care. Future studies are required to confirm findings for PPT.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay